| Literature DB >> 35895247 |
Chiara Chadwick1,2, Paul R Burton3,4, Jennifer Reilly3,5, Julie Playfair3, Cheryl Laurie3, Kalai Shaw3,4, Wendy A Brown3,4.
Abstract
PURPOSE: Bariatric surgery is an efficacious intervention for substantial and sustained weight reduction in individuals with morbid obesity resulting in health improvements. However, the changes to a patient's health related quality of life (HRQoL) in the medium to longer term after bariatric surgery have not been adequately characterized. Our aim was to evaluate the change to patient HRQoL 5 years following bariatric surgery in an Australian government-funded hospital system and determine the significance of relationships between change in physical and mental assessment scores and HRQoL utility scores.Entities:
Keywords: Bariatric surgery; HRQoL; QALY; Quality of life
Year: 2022 PMID: 35895247 PMCID: PMC9327972 DOI: 10.1007/s11695-022-06216-4
Source DB: PubMed Journal: Obes Surg ISSN: 0960-8923 Impact factor: 3.479
Participant demographics
| Number | |
|---|---|
| Gender | |
| Male | 20 (24.7%) |
| Female | 61 (75.3%) |
| Age at follow-up | |
| Mean (SD) | 52.25 years (10.49) |
| Follow-up time | |
| Mean (SD) | 5.72 years (1.07) |
| Baseline weight | |
| Mean (SD) | 130.59 kg (25.69) |
| Baseline BMI | |
| Mean (SD) | 48.12 kg/m2 (8.45) |
| Follow-up weight | |
| Mean (SD) | 112.7 kg (29.19) |
| Follow-up BMI | |
| Mean (SD) | 41.88 kg/m2 (11.21) |
| Total body weight loss | |
| Mean (SD) | 18.43 kg (20.61) |
| %TWL | |
| Mean (SD) | 13.57% (15.02) |
| Bariatric procedure | |
| LAGB | 76 |
| LSG | 4 |
| GB | 0 |
| BPD | 1 |
Participant comorbidities
| Comorbidity | Baseline ( | Follow-up ( | |
|---|---|---|---|
| Allergy | |||
| Hayfever | 31 | 30 | 0.92 |
| Cardiovascular | |||
| Hypertension | 47 | 51 | 0.45 |
| Dyslipidemia | 30 | 31 | 0.77 |
| Cardiac failure | 5 | 9 | 0.25 |
| Angina | 6 | 4 | 0.54 |
| Endocrine | |||
| Diabetes | 30 | 30 | 0.9 |
| Polycystic ovarian syndrome | 19 | 14 | 0.39 |
| Thyroid | 8 | 11 | 0.41 |
| Gastrointestinal | |||
| Gastroesophageal reflux | 42 | 54 | 0.06 |
| Gallstones | 10 | 13 | 0.52 |
| Fatty Liver disease | 4 | 7 | 0.33 |
| Peptic ulcer disease | 4 | 5 | 0.70 |
| Genitourinary | |||
| Renal disease | 9 | 10 | 0.69 |
| Urinary incontinence | 13 | 15 | 0.62 |
| Musculoskeletal | |||
| Arthritis | 37 | 46 | 0.23 |
| Back pain | 65 | 57 | 0.23 |
| Leg pain | 59 | 59 | 0.89 |
| Other joint pain | 2 | 8 | 0.06 |
| Neurological | |||
| Recurrent headaches | 37 | 28 | 0.19 |
| Psychological | |||
| Depression/anxiety | 46 | 42 | 0.84 |
| Respiratory | |||
| Asthma | 41 | 29 | 0.06 |
| OSA with CPAP | 20 | 24 | 0.50 |
| OSA no CPAP | 20 | 23 | 0.50 |
| Skin integrity | |||
| Skin fold irritation/rashes/ulcers | 25 | 25 | 1.0 |
| Leg ulcers | 32 | 20 | 0.06 |
Fig. 1Comparison of baseline and follow-up mean AQoL-8D weighted utility scores. ****P < 0.001, ***P < 0.005, **P < 0.01, *P < 0.05
Fig. 2Baseline vs follow-up mean RAND SF-36 domain scores. ****P < 0.001, ***P < 0.005, **P < 0.01, *P < 0.05
Fig. 3Change in depression severity index scores and severity
Fig. 4Change in mean Dakkak dysphagia severity (****P < 0.001)
Univariate correlation analysis of follow up AQoL utility and covariates
| Pearson | 95% CI | ||
|---|---|---|---|
| Change in BDI-II score | − 0.40 | < 0.001 | − 0.577 to − 0.187 |
| Change in Dakkak score | − 0.063 | 0.599 | - |
| Satisfaction with surgery | 0.581 | < 0.001 | 0.408 – 0.714 |
| % Total weight loss | 0.251 | 0.03 | 0.025 – 0.452 |
Multiple linear regression analysis follow-up AQoL utility and covariates
| Beta | 95% CI | ||
|---|---|---|---|
| Change in BDI-II score | − 0.005 | 0.029 | − 0.009 to − 0.001 |
| Change in Dakkak score | 0.094 | 0.319 | - |
| Satisfaction with surgery | 0.036 | < 0.001 | 0.022–0.051 |
| % Total weight loss | 0.07 | 0.492 | - |